Skip to main content
. 2021 Jan 22;3(3):100319. doi: 10.1016/j.ajogmf.2021.100319

Table 3.

Comparison of severe disease between pregnant and nonpregnant patients with symptomatic COVID-19

Clinical criteria for severe disease Symptomatic pregnant patients with COVID-19 (n=22) Symptomatic nonpregnant patients with COVID-19 (n=240) RR (95% CI) aRRa (95% CI)
Novel Coronavirus Pneumonia Emergency Response Epidemiology Team (NCPERET) criteria6 7 (31.8) 17 (7.1) 4.49b (2.09–9.64) 3.59b (1.49–7.01)
 Dyspnea 7 18
 Respiratory rate of >30 breaths/min 7 15
 Blood oxygen saturation of ≤93% 6 15
 PaO2/FiO2 ratio of <300c 2 8
 Lung infiltrates of >50% on imaging 6 15
WHO Ordinal Scale for Clinical Improvement (WHOOSCI)d 3 (13.6) 6 (2.50) 5.45b (1.46–20.32) 5.65b (1.36–17.31)
 Score 5: noninvasive ventilation or high-flow oxygen 1 4
 Score 6: intubation and mechanical ventilation. 0 0
 Score 7: ventilation with additional organ support (extracorporeal membrane oxygenation, renal replacement therapy, vasopressors) 2 2
P valuee
Length of stay, d 5 (1–15) 6 (1–25) .77
 Severe COVID-19 (NCPERET) 8 (1–15) 7 (1–29) .94
 Severe COVID-19 (WHOOSCI) 11 (8–15) 16 (1–29) .70
ICU admission 8 (36.4) 9 (3.75) <.01b
 Severe COVID-19 (NCPERET) 7 (100.0) 9 (50.0) .03b
 Severe COVID-19 (WHOOSCI) 3 (100.0) 5 (83.3) 1.00
Death 0 0

Data are presented as number (percentage) or median (range).

aRR, adjusted relative risk; CI, confidence interval; COVID-19, coronavirus disease 2019; ICU, intensive care unit; PaO2/FiO2, arterial oxygen partial pressure to fractional inspired oxygen; RR, relative risk; WHO, World Health Organization.

a

Determined using multivariable logistic regression adjusting for ethnicity and insurance type

b

Significant values

c

Values not available for 4 pregnant (4 of 22, 18.1%) and 8 nonpregnant patients (8 of 240, 3.3%)

e

Based on Wilcoxon rank-sum or Fisher exact test, as appropriate.

Oakes. Severe COVID-19 and pregnancy. Am J Obstet Gynecol MFM 2021.